deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03228914

Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery

Sponsor: The University of Texas Health Science Center, Houston

Conditions Endoscopic Sinus Surgery Nasal Polyps
Interventions Epinephrine Oxymetazoline
Updated 9 times since 2017 Last updated: Jan 7, 2021 Started: Jun 14, 2018 Primary completion: Aug 29, 2018 Completion: Aug 29, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03228914, this PHASE4 trial focuses on Endoscopic Sinus Surgery and Nasal Polyps and remains completed. Sponsored by The University of Texas Health Science Center, Houston, it has been updated 9 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~May 2019 · 11 months · monthly snapshotNot Yet Recruiting~May 2019 – ~Jan 2021 · 20 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotActive Not Recruiting~Feb 2021 – ~Dec 2022 · 22 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Feb 2021 — Dec 2022 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

▶ Show 4 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE4

  2. May 2019 — Jan 2021 [monthly]

    Active Not Recruiting PHASE4

    Status: Not Yet Recruiting → Active Not Recruiting

  3. Jun 2018 — May 2019 [monthly]

    Not Yet Recruiting PHASE4

  4. Aug 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The University of Texas Health Science Center, Houston
Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations